Early Access Program

Navigating the complexities of Named-Patient-Programs becomes seamless with Kaplan Pharma. We facilitate the supply of medications to individual patients, ensuring personalized and timely access to treatments, even when regulatory hurdles may arise. Our Early Access Program enables healthcare providers and patients to access promising pharmaceutical treatments before they are commercially available in their country. We are committed to accelerating medical advancements by providing early access to groundbreaking therapies.